Presentation

0 Comments

9 January 2017

PRODIGY and BRIDGE

Dr James Cotton

Review of the recent BRIDGE and PRODIGY trials

Previous | Next
Download

Summary

Trial vignettes of BRIDGE, a placebo controlled trial of Cangrelor in patients with ACS (n=210) who have received coronary stent and require bridging anti-platelet therapy while undergoing coronary artery bypass grafting; and PRODIGY a study of prolonged dual anti-platelet therapy (24 months vs 6 months) in an all-comers PCI population (75% ACS 25% SCAD).

Download

Summary

Trial vignettes of BRIDGE, a placebo controlled trial of Cangrelor in patients with ACS (n=210) who have received coronary stent and require bridging anti-platelet therapy while undergoing coronary artery bypass grafting; and PRODIGY a study of prolonged dual anti-platelet therapy (24 months vs 6 months) in an all-comers PCI population (75% ACS 25% SCAD).

You have to be a BCIS member to access this content

Either Sign in or register to become a member, today! Join BCIS Sign In